Skip to main content
. Author manuscript; available in PMC: 2017 Sep 25.
Published in final edited form as: J Nucl Med. 2015 Aug 27;56(12):1942–1947. doi: 10.2967/jnumed.115.160002

FIGURE 4.

FIGURE 4

PAT detects reduced vessel density and increased HbO2 in trebananib-treated mice. (A) THb photoacoustic (PA) signal in tumor ROI is significantly elevated in vehicle- compared with trebananib-treated mice; no significant difference is observed in contralateral ROI. (B) In trebananib-treated group, HbO2-weighted signal increases significantly, whereas Hb-weighted signal decreases significantly, over same time course. *P < 0.05. **P < 0.01.